arbiter
JournalsAccount

Value Relevance of Intangible Assets in Indian Pharmaceutical Industry: A Difference-in-difference Approach

Anurag Bhadur Singh et al.

FIIB Business Review2026https://doi.org/10.1177/23197145261425110article
AJG 1ABDC B
Weight
0.50

Abstract

This study attempts to investigate the value relevance of intangible assets reported in the financial statements of pharmaceutical companies listed on the BSE between 2011 and 2022. We investigate using panel data how intangible asset reporting, with the adoption of Indian Accounting Standards/International Financial Reporting Standards (IFRS) by Indian pharmaceutical firms, affects the market value of their shares. The unbalanced panel data set of 1,009 firm-year observations are used for analysis. Closing prices are taken as a proxy for firm value, gross intangible assets are the primary independent variable, while Earnings per share, net worth, cash flow, book value, firm size and market-to-book value, firm and year dummies are used as control variables. The fixed-effect model and difference-in-difference estimation are used for empirically investigating the linkage. Additionally, endogeneity issues are addressed, and robustness checks are done using various econometric tests. Based on empirical investigation, we discover that although value relevance of intangible assets has decreased in the post-IFRS period relative to the pre-IFRS, it still holds significance in forecasting the market value of the shares. The results will help policymakers evaluate the benefits and drawbacks of establishing accounting standards by adding to the body of knowledge already available on the value relevance of gross intangible accounting information.

Open via your library →

Cite this paper

https://doi.org/https://doi.org/10.1177/23197145261425110

Or copy a formatted citation

@article{anurag2026,
  title        = {{Value Relevance of Intangible Assets in Indian Pharmaceutical Industry: A Difference-in-difference Approach}},
  author       = {Anurag Bhadur Singh et al.},
  journal      = {FIIB Business Review},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1177/23197145261425110},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Value Relevance of Intangible Assets in Indian Pharmaceutical Industry: A Difference-in-difference Approach

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.